Ask a GDPR expert at Pharma Lawconvention, Berlin.
I've spent the last 2 days listening to experts on GDPR in the Life Science industry. There are about 120 working days until this...
Life Sciences
Contributors
-
Solicitor -
Of Counsel -
Partner -
Senior Associate -
Partner -
Senior Associate (Rechtsanwalt) -
Corporate Associate -
Special Counsel -
Partner -
Marketing Coordinator, International Practice Groups & Sectors
-
Partner -
Partner -
Global Co-Chair Life Science Partner -
Senior Marketing Manager -
-
Lawyer -
-
Senior Associate -
Partner, Healthcare Industry Sector -
Partner -
Partner -
Associate
-
-
-
Associate
-
Senior Associate
DLA Piper Life Sciences Archive
- July 2020 (1)
- June 2020 (1)
- May 2020 (2)
- April 2020 (6)
- March 2020 (1)
- February 2020 (2)
- January 2020 (4)
- November 2019 (2)
- October 2019 (1)
- August 2019 (1)
- July 2019 (5)
- May 2019 (6)
- March 2019 (2)
- February 2019 (4)
- January 2019 (1)
- December 2018 (2)
- November 2018 (2)
- October 2018 (1)
- August 2018 (1)
- July 2018 (2)
- May 2018 (1)
- April 2018 (3)
- March 2018 (8)
- February 2018 (1)
- December 2017 (5)
- November 2017 (15)
- October 2017 (7)
Livia Zamfiropol speaks at Pharma lawconvention of GDPR
A number of GDPR experts from pharma companies gathered in Berlin to discuss data privacy and GDPR. Livia Zamfiropol (DLA Piper partner)...
Checkpoint Inhibitors and Diabetes
PD-L1 and checkpoint inhibitors have been front and center in the media relating to the treatment of cancer. Researches are now...
Regulating High Cholesterol-A Never Ending Challenge
Researchers from Harvard identified a new protein, Nrf1, which regulates high cholesterol by binding directly to it. This binding prompts...
Human Embryonic Stem Cells to Treat Blindness
We have been hearing for a decade about the use of stem cells to create organs and treat diseases. Today, a study showing that hES...
Roche's Alecensa for Lung Cancer Gets a Nod from the FDA
Roche's Alecensa, a drug for treatment of ALK positive lung cancer, has received a nod from the FDA. While only 5% of lung cancer...
Sanofi Enters the Race to Develop a New Drug for Multiple Sclerosis
Sanofi has paid big bucks to enter the race to develop a new drug for MS. The drug was developed by Principia Biopharma and crosses the...
Transparency in Pay
In sectors where male employees hold the most senior jobs, and women are under-represented at all levels, the Gender Pay Gap Reports may...
Glacial progress or on the point of change?
The fact that this day remains unchanged from last year confirms that the pace of change has been ... rather less than "pacey". I...
Flexibility and expertise combined
Interesting article about fledgling creative ways of enabling tomorrow's employees acquire the hands- on practical experience and skills...
Medical devices and the smartphone's growing influence
Like many, I love finding out about how technology is shaping our lives and changing society. Deloitte's new research on smartphones
Do you know the top 10 most popular m-Health apps?
The m-Health market will reach approx. $ 26 billion globally by 2017 with a number of m-Health apps downloaded worldwide of about 3.2...
Taxing pads and tampons (or not). The Canary Islands innovate.
The regional government of the Canary Islands has decided to cut off the local value added tax applicable to sanitary pads and tampons....
Extending patent protection for life science companies
How far does the new doctrine of equivalents introduced by the UK Supreme Court in Eli Lilly v Actavis really extend the scope of patent...
Doctrine of equivalents: what's new in Continental Europe?
For the first time, in Eli Lilly v Actavis the UK Supreme Court has introduced a doctrine of equivalence in an effort to move closer to...
As a free user, you can follow Passle and like posts.
To repost this post to your own Passle blog, you will need to upgrade your account.
For plans and pricing, please contact our sales team at sales@passle.net